Fig. 2.
Fig. 2. Kaplan-Meier survival curves of CMML patients grouped according to patient characteristics identified by univariate analysis. / Survival curves for patients grouped by (A) WBC counts (≤ or > 13 × 109/L); (B) hemoglobin (HGB) level (≥ or < 120 g/L [12 g/dL]); (C) presence or absence of peripheral blood IMCs, (D) absolute lymphocyte count (≤ or > 2.5 × 109/L); and (E) bone marrow blast percentage (< or ≥ 10%). In each graph, the P value reflects the difference between the 2 Kaplan-Meier curves (log-rank test). Due to missing data, the total number of patients does not equal 213 in panels C, D, and E. Pts indicates patients; surv, survival.

Kaplan-Meier survival curves of CMML patients grouped according to patient characteristics identified by univariate analysis.

Survival curves for patients grouped by (A) WBC counts (≤ or > 13 × 109/L); (B) hemoglobin (HGB) level (≥ or < 120 g/L [12 g/dL]); (C) presence or absence of peripheral blood IMCs, (D) absolute lymphocyte count (≤ or > 2.5 × 109/L); and (E) bone marrow blast percentage (< or ≥ 10%). In each graph, the P value reflects the difference between the 2 Kaplan-Meier curves (log-rank test). Due to missing data, the total number of patients does not equal 213 in panels C, D, and E. Pts indicates patients; surv, survival.

Close Modal

or Create an Account

Close Modal
Close Modal